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Patent ductus arteriosus (PDA) is usually identiﬁed in childhood
ut sometimes is not detected until adult life. The adult patient
ith PDA is sometimes associated with congestive heart failure,
nd pulmonary hypertension [1–3]. The mortality is estimated to
e 1.8% per annum [1].
ndication of PDA closure
PDA closure is indicated in the following situations: (1) the pres-
nce of a PDA (except of the silent PDA and severe irreversible
ulmonary vascular diseases); (2) closure of the silent PDA remains
ontroversial and should not be routinely performed. However,
ilent PDA should be closed in the occurrence of an episode of
ndocarditis; (3) if pulmonary hypertension (pulmonary artery
ressure > 2/3 of systemic artery pressure or pulmonary artery
esistance > 2/3 of systemic arterial resistance) is present, there
ust be a net left to right shunt of 1.5:1 or more, or evidence of
ulmonary artery reactivity with reversibility test or lung biopsy
vidence that pulmonary arterial changes are potentially reversible
3,4].
ranscatheter closure of PDA
Surgical repair has been an established method. However, it may
e technically more difﬁcult in adults with possible calciﬁcation of
DA, requiring cardio-pulmonary bypass with an anterior approach
hrough a median sternotomy. In addition, advantages of trans-
atheter closure of PDA include the shorter hospital stay and no
car, compared with surgical repair. Thus, transcatheter closure has
ecome a ﬁrst-line treatment of most PDA in children and adults.
Although the implantation of a single or multiple coils of var-
ous sizes has been a safe procedure to complete occlusion [5], it
as limited success of complete closure when PDA is large. The
iameter of the PDA must be related to the size of patients, and the
roportion of large PDA is more common in older patients [2].  The
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ttp://dx.doi.org/10.1016/j.jccase.2013.01.004introduction of the Amplatzer duct occluder (ADO) offers the possi-
bility to close moderate to large size PDA by catheter intervention,
regardless of morphology. PDA closure using ADO has been proven
to be a safe and effective treatment [6,7].
Left ventricular dysfunction after closure of PDA
Several studies have demonstrated that PDA closure leads to
immediate deterioration of left ventricular (LV) systolic function,
which recovered within 6 months in neonates and children [8–10].
Galal et al. reported on a 12-year-old child in whom LV dysfunction
after large PDA closure occurred, and described a possible mech-
anism of deterioration of LV systolic function [9].  It was  Starling’s
effects resulting from the changes in pre-load and after-load sub-
sequent to closure. LV volume overload due to PDA is required to
increase LV volume and ejection fraction (EF) stretching the length
of LV muscle ﬁber according to Starling’s law. PDA closure results in
the sudden reduction of LV volume overload, thereby reducing the
LV ﬁber length and decreasing LVEF. Also, LV ejected blood into only
high resistance systemic circulation after PDA closure, although
it ejected into both high-resistance systemic circulation and low-
resistance pulmonary circulation before closure. They speculated
that changes in circulation increased LV after-load. In addition, pre-
vious reports have shown that the systolic and diastolic pressure
increase immediately after PDA closure [8,10].  The acute changes
in blood pressure may  also act to increase LV after-load immedi-
ately after PDA closure. Apart from the detailed mechanism of LV
dysfunction, Eerola et al. evaluated the effects of catheter closure
of PDA on the hemodynamic changes including LV systolic and dia-
stolic function in 37 children and concluded that the LV remodeling
and changes in systolic function that occurred immediately after
closure disappeared within 6 months [10]. In neonates, Kimball
et al. showed that wall stress and LV performance were main-
tained, although blood pressure and systemic resistance increased
after closure of PDA [8]. Thus, the ability of LV adaptation for acute
changes in pre- and after-load after PDA closure seems to depend
on the age of patients, the duration of left to right (L–R) shunt, or
magnitude of the shunt. With long-standing L–R shunt, the expo-
sure of LV volume overload leads to morphological changes in the
LV and results in impaired function. Thus, the LV function before
closure of PDA in adults could be impaired compared with that in
neonates and children. Jeong et al. analyzed the LV performance in
45 adult patients and concluded that the LVEF remained low late
after PDA closure compared with the pre-closure state. They also
showed that pre-closure LVEF was  the independent predictor of
late normal post-closure LVEF and the pre-closure LVEF > 62% had a
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ensitivity of 72% and a speciﬁcity of 83% for predicting late normal
F after closure [11].
In contrast to the previous reports, the LVEF returned to the nor-
al  range of 68%, even when pre-closure LVEF was 50% and ﬁbrosis
as observed in the LV wall in the case reported by Fujii et al. [12].
edical therapy such as with angiotensin receptor blockers may
ffect the recovery of LV dysfunction caused by PDA closure [12].
LV diastolic function could also be impaired in adults with PDA.
owever, there are few studies examining the LV diastolic function
10]. A recent report showed that LV diastolic dysfunction occurred
n adult patients with repaired tetralogy of Fallot (TOF) in whom
hronic pulmonary regurgitation impaired right ventricular func-
ion, and it was one of the predictors of late onset of arrhythmia
13].
rrhythmias in adults with PDA
It is well known that atrial ﬁbrillation and/or atrial ﬂutter occur
n congestive heart failure due to chronic volume overload by PDA
1–4,14]. However, ventricular tachycardia (VT) is rare in adults
ith PDA [15]. There is a great risk of VT developing in patients
ho have undergone a ventriculotomy and/or patching for ventri-
ular septal defect. Less commonly, VT can develop independently
f direct surgical scarring whenever a long-standing hemodynamic
verload causes ventricular dysfunction or hypertrophy. Lesions of
ongenital heart disease that can develop VT include aortic steno-
is, corrected transposition of the great arteries, Ebstein anomaly,
ingle ventricle, Eisenmenger’s syndrome, and unrepaired TOF [15].
DA is a L–R shunt lesion that results in left heart volume overload.
n the case reported by Fujii et al., VT originated from the right ven-
ricular outﬂow tract, whereas pulmonary artery hypertension was
ild [12]. Therefore, it is unclear about the relation between VT and
DA.
In summary, further studies are needed in adults with PDA
o clarify: (1) the LV remodeling including diastolic function and
rrhythmia before and after closure of PDA; and (2) effects of med-
cal therapy and prevention of the LV dysfunction after closure of
DA.eferences
[1] Cambell M.  Natural history of patent ductus arteriosus. Br Heart J 1968;30:4–13.
[2] Hoffman JIE. Patent ductus arteriosus. In: The natural and unnatural history of
congenital heart disease. Oxford: Blackwell; 2009. p. 79–92. Cases 7 (2013) e89–e90
[3] Schneider DJ, Moore JW.  Patent ductus arteriosus. Circulation 2006;114:
1873–82.
[4]  Silversides CK, Dore A, Poirier N, Taylor D, Harris L, Greutmann M,  Benson L,
Baumgartner H, Celermajer D, Therrien J. Canadian Cardiovascular Society 2009
Consensus Conference on the management of adults with congenital heart
disease: shunt lesions. Can J Cardiol 2010;26:e70–9.
[5]  Hofbeck M,  Bartolomaeus G, Buheitel G, Esser R, Grävinghoff L, Hoffmann W,
Kienast W,  Michel-Behnke I, Scharabrine EG, Schranz D, Schmaltz AA, Shakhov
BE,  Singer H, Lindinger A. Safety and efﬁcacy of interventional occlusion of
patent ductus arteriosus with detachable coils: a multicentre experience. Eur J
Pediatr 2000;159:331–7.
[6] Bilkis AA, Alwi M,  Hasri S, Haifa AL, Geetha K, Rehman MA,  Hasanah I.
The  Amplatzer duct occluder: experience in 209 patients. J Am Coll Cardiol
2001;37:258–61.
[7] Masura J, Tittel P, Gavora P, Podnar T. Long-term outcome of transcatheter
patent ductus arteriosus closure using Amplatzer duct occluders. Am Heart J
2006;151:755.e7–10.
[8] Kimball TR, Ralston MA,  Khoury P, Crump RG, Cho FS, Reuter JH. Effect of
ligation of patent ductus arteriosus on left ventricular performance and its
determinants in premature neonates. J Am Coll Cardiol 1996;27:193–7.
[9] Galal MO,  Amin M,  Hussein A, Kouatli A, Al-Ata J, Jamjoom A. Left ventricular
dysfunction after closure of large patent ductus arteriosus. Asian Cardiovasc
Thorac Ann 2005;13:24–9.
10] Eerola A, Jokinen E, Boldt T, Pihkala J. The inﬂuence of percutaneous closure of
patent ductus arteriosus on left ventricular size and function. J Am Coll Cardiol
2006;47:1060–6.
11] Jeong YH, Yun TJ, Song JM,  Park JJ, Seo DM, Koh JK, Lee SW,  Kim MJ,  Kang
DH,  Song JK. Left ventricular remodeling and change of systolic function after
closure of patent ductus arteriosus in adults: Device and surgical closure. Am
Heart J 2007;154:436–40.
12] Fujii T, Tomita H, Iwasaki J, Sawada M,  Soga T, Tanno K, Sakai T, Kobayashi Y,
Itabashi K, Uemura S. Restored left ventricular function following transcatheter
closure of a persistent ductus arteriosus. J Cardiol Cases 2013;7:e64–7.
13] Khairy P, Aboulhosn J, Gurvitz MZ,  Opotowsky AR, Mongeon FP, Kay J, Valente
AM,  Earing MG, Lui G, Gersony DR, Cook S, Ting JG, Nickolaus MJ,  Webb G,
Landzberg MJ,  et al. Arrhythmia burden in adults with surgically repaired
tetralogy of Fallot: a multi-institutional study. Circulation 2010;122:868–75.
14] Bouchardy J, Therrien J, Pilote L, Ionescu-Ittu R, Martucci G, Bottega N, Marelli
AJ.  Atrial arrhythmia in adults with congenital heart disease. Circulation
2009;120:1679–86.
15] Walsh EP, Cecchin F. Arrhythmias in adult patients with congenital heart dis-
ease. Circulation 2007;115:534–45.
Yoshiki Mori (MD) ∗
Division of Pediatric Cardiology, Seirei Hamamatsu
General Hospital, 2-12-12 Sumiyoshi, Naka-ku,
Hamamatsu, Shizuoka 162-8666, JapanE-mail address: y.mori@sis.seirei.or.jp
28 November 2012
